| A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies AO Hassan, JB Case, ES Winkler, LB Thackray, NM Kafai, AL Bailey, ... Cell 182 (3), 744-753. e4, 2020 | 527 | 2020 |
| Human germinal centres engage memory and naive B cells after influenza vaccination JS Turner, JQ Zhou, J Han, AJ Schmitz, AA Rizk, WB Alsoussi, T Lei, ... Nature 586 (7827), 127-132, 2020 | 242 | 2020 |
| Germinal centre-driven maturation of B cell response to mRNA vaccination W Kim, JQ Zhou, SC Horvath, AJ Schmitz, AJ Sturtz, T Lei, Z Liu, ... Nature 604 (7904), 141-145, 2022 | 240 | 2022 |
| A potently neutralizing antibody protects mice against SARS-CoV-2 infection WB Alsoussi, JS Turner, JB Case, H Zhao, AJ Schmitz, JQ Zhou, RE Chen, ... The Journal of Immunology 205 (4), 915-922, 2020 | 189 | 2020 |
| SARS-CoV-2 Omicron boosting induces de novo B cell response in humans WB Alsoussi, SK Malladi, JQ Zhou, Z Liu, B Ying, W Kim, AJ Schmitz, T Lei, ... Nature 617 (7961), 592-598, 2023 | 98 | 2023 |
| Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans AH Ellebedy, R Nachbagauer, KJL Jackson, YN Dai, J Han, WB Alsoussi, ... Proceedings of the National Academy of Sciences 117 (30), 17957-17964, 2020 | 67 | 2020 |
| A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants AJ Schmitz, JS Turner, Z Liu, JQ Zhou, ID Aziati, RE Chen, A Joshi, ... Immunity 54 (9), 2159-2166. e6, 2021 | 56 | 2021 |
| Human antibodies targeting influenza B virus neuraminidase active site are broadly protective A Madsen, YN Dai, M McMahon, AJ Schmitz, JS Turner, J Tan, T Lei, ... Immunity 53 (4), 852-863. e7, 2020 | 54 | 2020 |
| SARS-CoV-2 viral RNA shedding for more than 87 days in an individual with an impaired CD8+ T cell response JS Turner, A Day, WB Alsoussi, Z Liu, JA O’Halloran, RM Presti, ... Frontiers in immunology 11, 618402, 2021 | 28 | 2021 |
| Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccination W Kim, JQ Zhou, AJ Sturtz, SC Horvath, AJ Schmitz, T Lei, E Kalaidina, ... Biorxiv, 2021 | 17 | 2021 |
| A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants AJ Schmitz, JS Turner, Z Liu, ID Aziati, RE Chen, A Joshi, TL Bricker, ... BioRxiv, 2021 | 17 | 2021 |
| Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo L Hansen, M McMahon, HL Turner, X Zhu, JS Turner, G Ozorowski, ... Immunity 56 (8), 1927-1938. e8, 2023 | 9 | 2023 |
| Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination M Quinn, L Parra-Rodriguez, WB Alsoussi, C Ayres, MK Klebert, C Liu, ... The Journal of Immunology 210 (7), 947-958, 2023 | | 2023 |
| ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES A Ellebedy, A Schmitz, J Turner, W Al Soussi, M Diamond, D Fremont, ... US Patent App. 17/232,796, 2022 | | 2022 |
| Protection Against Influenza B Viruses by Human Monoclonal Antibodies that Target the Neuraminidase Active Site A Madsen, YN Dai, M Mcmahon, A Schmitz, J Turner, J Tan, T Lei, ... | | |
